| Design and synthesis of N‑(benzylpiperidinyl)‑4‑fluorobenzamide: A haloperidol analog that reduces neuropathic nociception via σ1 receptor antagonism M Déciga-Campos, LA Melo-Hernández, H Torres-Gómez, B Wünsch, ... Life sciences 245, 117348, 2020 | 13 | 2020 |
| Antinociceptive effects of a new sigma-1 receptor antagonist (N-(2-morpholin-4-yl-ethyl)-2-(1-naphthyloxy) acetamide) in two types of nociception BA García-Martínez, OA Jaramillo-Morales, JV Espinosa-Juárez, ... European Journal of Pharmacology 771, 10-17, 2016 | 13 | 2016 |
| N-(2-morpholin-4-yl-ethyl)-2-(1naphthyloxy) acetamide inhibits the chronic constriction injury-generated hyperalgesia via the antagonism of sigma-1 receptors JV Espinosa-Juárez, OA Jaramillo-Morales, G Navarrete-Vázquez, ... European journal of pharmacology 812, 1-8, 2017 | 9 | 2017 |
| Síntesis y evaluación del efecto antinociceptivo de benzamidas piperidínicas y morfolínicas LAM HERNANDEZ El autor, 2019 | | 2019 |
| Design, synthesis and in combo activity of selective sigma-1 receptor ligands with robust antinociceptive effect G Navarrete Vazquez, B Godinez-Chaparro, F Lopez-Munoz, B Wuensch, ... ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 252, 2016 | | 2016 |
